Health Products

Dimension Clinical Chemistry, Vista, XPAND and EXL Systems (Iron Assays)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
All lots.
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark, Delaware
19714-6101
UNITED STATES
D. Dimension Exl System - Iron (Iron) AssayDF85
All lots.
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark, Delaware
19714-6101
UNITED STATES
B. Dimension Vista System - Iron AssayK3085
All lots.
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark, Delaware
19714-6101
UNITED STATES
C. Dimension Xpand System - Iron (Iron) AssayDF85
All lots.
Manufacturer
Siemens Healthcare Diagnostics Inc.
500 GBC DRIVE, MAILSTOP 514, P.O. BOX 6101
Newark, Delaware
19714-6101
UNITED STATES
A. Dimension Clinical Chemistry System - Iron Flex Reagent CartridgeDF85

Introduction

Affected Products
  1. Dimension Clinical Chemistry System - Iron Flex Reagent Cartridge
  2. Dimension Vista System - Iron Assay
  3. Dimension Xpand System - Iron (Iron) Assay
  4. Dimension Exl System - Iron (Iron) Assay

Reason

Siemens Healthcare Diagnostics has become aware of Deferoxamine interference with dimension and dimension vista iron assays at a different concentration than listed in the instructions for use (IFU). Deferoxamine is listed in the dimension and dimension vista IFU's as a non-interfering substance. The concentration that was used for interference testing (250 NG/DL or 3.8 nmol/l) is significantly below what would be expected in clinical practice.                  Siemens Healthcare Diagnostics is providing an update to the limitation of procedure section for the dimension and dimension vista iron assays instructions for use (IFU) to indicate that: patients treated with metal-binding drugs (e.g. Deferoxamine) may have depressed iron values, as chelated iron may not properly react in the iron assay.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime